Fatigue, a common presenting symptom in clinical practice, poses a significant diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive clinical approach to diagnosing and managing fatigue, focusing on the intricate interplay of various contributing factors.
Diagnosing fatigue requires a detailed patient history and physical examination. The clinician should evaluate the duration, onset, and severity of fatigue, along with associated symptoms. Potential contributing factors such as sleep disturbances, psychiatric conditions, and lifestyle factors should also be identified. Laboratory tests, including complete blood count, thyroid function tests, and inflammatory markers, can further assist in identifying underlying medical conditions.
Management of fatigue is primarily tailored to the underlying cause. For instance, sleep disorders may require interventions such as cognitive-behavioral therapy for insomnia or continuous positive airway pressure for sleep apnea. In cases of depression or anxiety, pharmacological treatment and psychotherapy may be beneficial. Lifestyle modifications including regular physical activity, balanced nutrition, and stress management strategies can also play a crucial role in managing fatigue.
A multidisciplinary approach is essential in managing fatigue due to its complex nature. Collaboration between primary care physicians, psychiatrists, sleep medicine specialists, and dieticians can ensure comprehensive care. Such an approach allows for the identification and management of multiple contributing factors, thus improving patient outcomes.
Understanding the complexities of fatigue, its multifactorial etiology, and the need for a comprehensive, individualized approach to diagnosis and management is crucial. A multidisciplinary approach ensures that all potential contributing factors are addressed, providing the best possible care for patients experiencing fatigue. Continued research and education in this area are essential to further improve diagnostic accuracy and treatment efficacy.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation